This study compares China and the United States from a patient-centered lens: what a typical resident pay, how predictable those costs are, and how quickly care can be accessed. Using accessible official reports and policy briefs, the analysis focuses on three parts that shape everyday experience-coverage architecture, drug pricing and reimbursement, and provider payment. China combines broad social insurance with provincial risk pooling, centralized drug procurement, and DRG/DIP payment reforms that compress prices and start shifting demand toward primary care. The U.S. keeps a plural structure that supports choice and innovation, but complex benefits and plan churn can raise out-of-pocket risk; recent steps-Medicare drug price negotiation, marketplace subsidies, and moves toward site-neutral payment-aim to reduce volatility. Based on this comparison, the paper proposes three practical actions that ordinary patients can feel: (1) real-time out-of-pocket estimates at prescribing and check-in; (2) clear monthly caps for common chronic medicines; and (3) stronger team-based primary care as a stable “front door.” These options are incremental, fiscally realistic, and measurable through simple indicators such as waiting time, essential-medicine availability, and the share of households facing large medical bills.
Research Article
Open Access